MEDCURA, INC.

Profile

Company Names

MEDCURA, INC.
GEL-E, INC.
REMEDIUM TECHNOLOGIES, INC.

Addresses

5650 RIVERTECH COURT, SUITE S, RIVERDALE, MD 20737

5650 RIVERTECH COURT, SUITE S, RIVERDALE, MD 20737

5650 RIVERTECH COURT, SUITE S., RIVERDALE, MD 20737

387 TECHNOLOGY DR., COLLEGE PARK, MD 20742

Phone Numbers

3014053585
(240) 684-8801
301-405-3585

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$60,180,808.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2025-04-16 
$28,548,588.00 
$38,286,410.00 
$9,737,822.00 
Equity 
6
2022-07-29 
$22,486,953.00 
$22,800,000.00 
$313,047.00 
Equity, Debt 
5
2021-10-15 
$3,490,000.00 
$5,761,644.00 
$2,271,644.00 
Equity, Debt 
4
2020-06-19 
$3,021,475.00 
$5,000,000.00 
$1,978,525.00 
Debt 
3
2018-06-18 
$1,561,500.00 
$2,500,000.00 
$938,500.00 
Debt 
2
2016-09-09 
$1,072,281.00 
$3,100,000.00 
$2,027,719.00 
Equity 
1
2016-03-29 
$11.00 
$200.00 
$189.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ABBAS 
 
ARDEHALI, M.D. 
DIRECTOR
ALEX 
 
ARROW 
DIRECTOR
JIM 
 
BUCK 
DIRECTOR, EXECUTIVE OFFICER
MATTHEW 
 
DOWLING 
EXECUTIVE OFFICER, DIRECTOR
MATTHEW 
 
DOWLING, PH.D 
DIRECTOR, EXECUTIVE OFFICER
PETER 
 
THOMAS 
EXECUTIVE OFFICER, DIRECTOR
LARRY 
 
TIFFANY 
EXECUTIVE OFFICER, DIRECTOR
RICH 
 
VINCENT 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-07-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-07-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-10-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-06-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
DONALD CAPITAL LLC
NONE
NONE